DSIJ Mindshare

Multibagger penny stock under Rs 60 with 200 per cent returns: Heavy buying witnessed in this pharma stock; PAT jumps over 240 per cent!

Shares of the company gained more than 10 per cent in the last six months.

Praveenkumar Yadav 0 5576 Article rating: 4.0

Shares of the company gained more than 10 per cent in the last six months.

Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds!

The company saw strong volume growth across key markets, particularly the US, indicating rising demand for their products.

Aniket Gogate 0 7870 Article rating: 4.0

Institutional investor interest in the stock has risen significantly, with Foreign Institutional Investor (FII) holdings increasing to 15.55 per cent in the quarter ending December 2023 from 4.23 per cent in December 2022.

Amansa Holding buys 11,40,301 shares of small-cap multibagger pharma stock; company reduces debt and presents special situation opportunity!

Moreover, the company's announcement regarding the creation of OneSource in September 2023 marks a pivotal value enhancement opportunity for Strides shareholders

Karan Dsij 0 15877 Article rating: 3.8

Of significant note is the remarkable reduction in the company's debt-to-EBITDA ratio, which has undergone a substantial decline from 5.7x in FY'22 to 2.8x on an annualized quarterly basis, signaling a notable financial transformation. Despite surpassing guidance in debt reduction, the company continues to generate free cash flow

Multibagger in just 1 month: Keep an eye on this stock, which was locked in the upper circuit on February 07

The stock gave multibagger returns of 141.35 per cent in just 1 month whereas BSE Small-cap Index is down by 3.36 per cent.

Kiran Shroff 0 9452 Article rating: 4.2

The stock gave multibagger returns of 141.35 per cent in just 1 month whereas BSE Small-cap Index is down by 3.36 per cent.

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR